Babylon (BBLN) Announces Take-Private Transaction with MindMaze
by Marlena Haddad on 2023-06-23 at 12:41pm

Babylon (NYSE:BBLN) provided an update this morning on its recapitalization transaction, announcing that it has accepted a take-private proposal from AlbaCore on behalf of its affiliate, digital neurotherapeutic platform MindMaze.

The parties expect the transaction to close by July, but as the two companies work to come together within the next few weeks, they will both continue executing their day-to-day operations. Over the mid-to-long term, Babylon and MindMaze intend to align the strengths of their organizations to deliver a novel care paradigm and deliver exceptional outcomes for all stakeholders.

The transaction establishes a new capital structure that reduces the pro forma company debt. It will also include immediate funding for Babylon’s current business operations and funds for the combined company, allowing it to focus on delivering growth and profitability over the near to mid-term.

As a result, Babylon will transfer its core operating subsidiaries to MindMaze and Babylon’s Class A ordinary shares will cease trading on the NYSE under the ticker symbol ‘BBLN’.

Additionally, the take-private proposal will not provide for any payment towards Babylon’s Class A ordinary shareholders as AlbaCore intends to exercise its rights under its debt agreements with Babylon.

Just last month, Babylon announced its plan to go private as it entered into an amendment and restatement of its senior secured term loan facility with AlbaCore for up to an additional $34.5 million in funding. The de-SPAC believes that this proposal will strongly position the company to accelerate its core mission of making high-quality healthcare more accessible and affordable.

InsureTech firm Babylon closed its $3.6 billion combination with Alkuri Global less than two years ago in October 2021. London-based Babylon provides digital self-help care tools and telemedicine services to patients in North America, Europe and Asia.

 

Recent Posts
by Marlena Haddad on 2023-12-07 at 10:38am

FG Merger III Corp. filed for a $150 million IPO yesterday afternoon, marking the third SPAC to file on Wednesday. Similar to Blue Room (NASDAQ:IBLUU), which filed its $200 million IPO yesterday morning, FG Merger III intends to focus its search for a target business in the financial services industry in North America. Notably, FG...

by Marlena Haddad on 2023-12-07 at 7:55am

10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA) announced that it has completed its business combination with African Agriculture after shareholders approved the deal at a special meeting held on December 5. In connection with the meeting, 10X II received redemption requests for 1,857,033 Class A ordinary shares, representing 98.7% in aggregate redemptions since 10X II’s...

by Nicholas Alan Clayton on 2023-12-07 at 7:52am

At the SPAC of Dawn The latter half of 2023 has largely told a story of retrenchment in the SPAC market as much of the excess in the domain has found itself terminating and liquidating. But, the increase in outgoing has not completely canceled out the boom in incoming as three new SPACs filed to...

by Nicholas Alan Clayton on 2023-12-06 at 4:17pm

TechyBird Acquisition Corp. (NASDAQ:TKBD) filed for a $60 million IPO today, putting it in line to become the second 2023 IPO from an underwriter that is relatively new to the SPAC space. That underwriter, Spartan Capital Securities, brought Aimei Health Technology (NASDAQ:AFJK) to market last week with similar terms as this new member to its...

by Marlena Haddad on 2023-12-06 at 1:32pm

Blue Room Acquisition Corp. (NASDAQ:IBLUU) submitted its S-1 filing this morning for a $200 million IPO. The new SPAC has set its sights on targets in the financial sector, ranging in market value between $250 million and $500 million, and primarily situated in the U.S. Its primary objective is to identify an innovative company leveraging...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved